In breast cancer, Rac and Cdc42 dysregulation can be attributed to overexpression due to gene amplification and mRNA upregulation, hyperactivity via the upstream regulators guanine nucleotide exchange factors (GEF), overexpression of oncogenic cell surface receptors, or a combination of these (7, 8). Here, CDC42 is linked to breast cancer.